Guardant Health, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc., sold 46,300 shares of common stock on August 12, 2026.
NASDAQ
Helmy Eltoukhy, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 11, 2026.
NASDAQ
Amirali Talasaz, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 10, 2026.
NASDAQ
John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported a transaction in 800 shares of common stock on August 10, 2026.
NASDAQ
Chris Freeman, Chief Commercial Officer of Guardant Health, Inc., sold 63,605 shares of common stock on August 10, 2026.
NASDAQ
Medina Manuel Hidalgo, a Director of Guardant Health, Inc., sold 1,700 shares of common stock on August 5, 2026.
NASDAQ
Ian T Clark, a Director of Guardant Health, Inc., sold 14,180 shares of common stock on August 4, 2026.
NASDAQ
Roberto Mignone, a Director of Guardant Health, Inc., reported multiple transactions in common stock on July 21, 2026.
NASDAQ
Medina Manuel Hidalgo, a Director of Guardant Health, Inc., reported multiple transactions in common stock on July 17, 2026.
NASDAQ
Musa Tariq, a Director of Guardant Health, Inc., sold 116 shares of common stock on July 15, 2026 for $163.29 per share.
NASDAQ
Guardant Health's Chief Legal Officer, John G. Saia, reported transactions involving the acquisition of common stock and restricted stock units.
NASDAQ
Terilyn J. Monroe, Chief People Officer at Guardant Health, Inc., reported transactions involving restricted stock units and common stock.
NASDAQ
Guardant Health, Inc. executive Kumud Kalia reported transactions involving the acquisition of common stock and restricted stock units.
NASDAQ
Guardant Health's Chief Commercial Officer, Chris Freeman, reported transactions involving the acquisition of common stock and restricted stock units.
NASDAQ
Darya Chudova, Chief Technology Officer at Guardant Health, Inc., reported transactions involving restricted stock units and common stock.
NASDAQ
Guardant Health's Chief Financial Officer, Michael Brian Bell, acquired shares through the vesting of restricted stock units and retained shares for tax withholding.
NASDAQ
Guardant Health Co-CEO Helmy Eltoukhy reported transactions involving common stock and restricted stock units on June 30 and July 1, 2026.
NASDAQ
AmirAli Talasaz, Co-Chief Executive Officer and Director of Guardant Health, Inc., reported transactions involving common stock and restricted stock units.
NASDAQ
Guardant Health Director Steve Krognes acquired 155 shares of common stock through the vesting of restricted stock units.
NASDAQ
Guardant Health's Chief Information Officer, Kumud Kalia, has paid $192 to the company to settle recoverable Section 16(b) short-swing profits from recent stock transactions.
NASDAQ
AmirAli Talasaz, Co-Chief Executive Officer and Director of Guardant Health, Inc., reported transactions involving the sale of common stock and acquisition of stock options.
NASDAQ
Chief Information Officer Kumud Kalia acquired 638 shares of Guardant Health common stock via RSU vesting, with 314 shares withheld for taxes.
NASDAQ
Director Tariq Musa reported the vesting of restricted stock units and a subsequent sale of Guardant Health common stock.
NASDAQ
Chief Legal Officer John G. Saia acquired 1,020 shares of Guardant Health common stock via RSU vesting, with 535 shares withheld for taxes.
NASDAQ
Chief Commercial Officer Chris Freeman acquired 1,402 shares of Guardant Health common stock via restricted stock unit vesting.
NASDAQ
Guardant Health CFO Michael Brian Bell acquired 2,039 shares via RSU vesting and withheld 1,096 shares for tax obligations.
NASDAQ
Form 4: Guardant Health CIO Sells Shares
Guardant Health Chief Information Officer Kumud Kalia sold 3,418 shares of common stock on June 11, 2026.
NASDAQ
Guardant Health Chief Information Officer Kumud Kalia sold 5,000 shares of common stock on June 10, 2026.
NASDAQ
Co-Chief Executive Officer Helmy Eltoukhy sold 100,000 shares of Guardant Health common stock on June 5, 2026.
NASDAQ
Guardant Health Chief Financial Officer Michael Brian Bell sold 2,000 shares of common stock on June 5, 2026.